AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8533868 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia (BAL): 2.6 mg droperidol and 0.004 mg/kg body weight fentanyl with 0.4 vol.% isoflurane
Number of subjects: 1318
Study 2148278 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (2 X bolus 0.5 mg/kg; infusion 5.0 micrograms/kg/min)
Number of subjects: 0
Study 2148278 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (3.0‐4.0 micrograms/kg/min)
Number of subjects: 0
Study 2148278 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline-Ephedrine
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline-Ephedrine-Hydroxyzine
Number of subjects: 0
Study 7386944 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine alone
Number of subjects: 0
Study 7386944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31117100 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated Lactobacillus paracasei GM-080
Number of subjects: 0
Study 31117100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28527788 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based inhibition training on a tablet for two months
Number of subjects: 0
Study 28527788 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study 28527788 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 0
Study 28527788 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based inhibition training
Number of subjects: 0
Study 25893825 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stromal cell telomere lengths (below median)
Number of subjects: 82
Study 25893825 — intervention group
Group type: COMPARATOR
Intervention: Normal-appearing basal cell telomere lengths (short)
Number of subjects: 82
Study 25893825 — intervention group
Group type: COMPARATOR
Intervention: Luminal cell telomere lengths (short)
Number of subjects: 82
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine
Number of subjects: 135
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylcellulose
Number of subjects: 135
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 135
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Regul8 with nurse support
Number of subjects: 135
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Regul8 with minimal email support
Number of subjects: 135
Study 23602047 — intervention group
Group type: COMPARATOR
Intervention: No website
Number of subjects: 135
Study 23602047 — intervention group
Group type: EXPERIMENTAL
Intervention: Regul8 groups
Number of subjects: 135
Study 21409403 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained
Number of subjects: 23
Study 21409403 — intervention group
Group type: COMPARATOR
Intervention: Untrained
Number of subjects: 23
Study 19727967 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordance score
Number of subjects: 1240
Study 19727967 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic score
Number of subjects: 1240
Study 19727967 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly concordant co-morbid conditions
Number of subjects: 1240
Study 19727967 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly symptomatic conditions
Number of subjects: 1240
Study 17329193 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 2923
Study 17329193 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 2923
Study 17329193 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy for SCC
Number of subjects: 2923
Study 17329193 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy for adenocarcinoma
Number of subjects: 2923
Study 15057583 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse incision
Number of subjects: 28
Study 15057583 — intervention group
Group type: COMPARATOR
Intervention: Vertical midline incision
Number of subjects: 28
Study 11176732 — intervention group
Group type: EXPERIMENTAL
Intervention: Active guideline-based advice exposure
Number of subjects: 212
Study 11176732 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive guideline-based advice exposure
Number of subjects: 212
Study 11176732 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 11096410 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercises
Number of subjects: 58
Study 11096410 — intervention group
Group type: COMPARATOR
Intervention: Pelvic muscle exercises plus electrical stimulation
Number of subjects: 58
Study 11096410 — intervention group
Group type: EXPERIMENTAL
Intervention: IIQ-7 scores
Number of subjects: 58
Study 8864327 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin alone (600 mg)
Number of subjects: 12
Study 8864327 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin with atovaquone (600 mg phenytoin + 2000 mg atovaquone as two doses of 1000 mg)
Number of subjects: 12
Study 1824654 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 266
Study 1824654 — intervention group
Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 266
Study 6868097 — intervention group
Group type: EXPERIMENTAL
Intervention: Syringe and needle (0.5 ml)
Number of subjects: 109
Study 6868097 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet-injector (0.1 ml)
Number of subjects: 109
Study 6868097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nose drops (0.5 ml)
Number of subjects: 109
Study 6868097 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifurcated needle
Number of subjects: 109
Study 6868097 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle planted cylinder
Number of subjects: 109
Study 6868097 — intervention group
Group type: COMPARATOR
Intervention: Control group (24 children)
Number of subjects: 109
Study 30785053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 117
Study 30785053 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 117
Study 30785053 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE)
Number of subjects: 117
Study 30181436 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ)
Number of subjects: 15
Study 30181436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 27687397 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 120
Study 27687397 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 120
Study 27687397 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin 75 mg
Number of subjects: 120
Study 27687397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 24315404 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT)
Number of subjects: 338
Study 24315404 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT)
Number of subjects: 338
Study 22168752 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with autoimmune thyroiditis (AT)
Number of subjects: 158
Study 22168752 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid controls
Number of subjects: 158
Study 22168752 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with nontoxic multinodular goiter
Number of subjects: 158
Study 20156896 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity training (HFT)
Number of subjects: 98
Study 20156896 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity training (LFT)
Number of subjects: 98
Study 20156896 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 98
Study 20156896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups
Number of subjects: 98
Study 17595001 — intervention group
Group type: EXPERIMENTAL
Intervention: Role Induction (RI)
Number of subjects: 353
Study 17595001 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 353
Study 16172439 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific program administered by rheumatologists including education, protocol-based clinical management, and administrative duties.
Number of subjects: 1077
Study 16172439 — intervention group
Group type: COMPARATOR
Intervention: Standard primary care management with referral to specialized care if needed (control group).
Number of subjects: 1077
Study 11840224 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg once daily
Number of subjects: 220
Study 11840224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 10067658 — intervention group
Group type: EXPERIMENTAL
Intervention: FM containing Lactobacillus acidophilus L1
Number of subjects: 0
Study 7742148 — intervention group
Group type: EXPERIMENTAL
Intervention: LTD4
Number of subjects: 20
Study 7742148 — intervention group
Group type: EXPERIMENTAL
Intervention: PGD2
Number of subjects: 20
Study 2403062 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg vitamin A preparation
Number of subjects: 2471
Study 2403062 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg vitamin A preparation
Number of subjects: 2471
Study 2403062 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg vitamin A preparation)
Number of subjects: 2471
Study 30168905 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-117 tablet (900 mg)
Number of subjects: 0
Study 30168905 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-117 (600 mg) under fed conditions (high-fat meal)
Number of subjects: 0
Study 30168905 — intervention group
Group type: COMPARATOR
Intervention: TAK-117 (900 mg) plus lansoprazole
Number of subjects: 0
Study 30473033 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping (DCC, >5 minutes)
Number of subjects: 73
Study 30473033 — intervention group
Group type: COMPARATOR
Intervention: Immediate clamping (ICC, <20 seconds)
Number of subjects: 73
Study 26681677 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SPCG-6 study)
Number of subjects: 263
Study 25318563 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's Health CoOp (behavioral intervention)
Number of subjects: 0
Study 25318563 — intervention group
Group type: COMPARATOR
Intervention: Standard HIV testing and referral for treatment (control)
Number of subjects: 0
Study 22766124 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tramadol 50 mg capsules (n = 35)
Number of subjects: 103
Study 22766124 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 550 mg tablets (n = 34)
Number of subjects: 103
Study 22766124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 34)
Number of subjects: 103
Study 21415811 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 38
Study 21415811 — intervention group
Group type: COMPARATOR
Intervention: Posterior lumbar decompression surgery
Number of subjects: 38
Study 17350802 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (Zn) 0.59 mg as zinc sulfate with 0.5 mg Fe as ferrous sulfate
Number of subjects: 14
Study 17350802 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (Zn) 11.71 mg as zinc sulfate with 10 mg Fe
Number of subjects: 14
Study 17350802 — intervention group
Group type: COMPARATOR
Intervention: Iron (Fe) 0.5 mg as ferrous sulfate alone
Number of subjects: 14
Study 17350802 — intervention group
Group type: COMPARATOR
Intervention: Iron (Fe) 10 mg alone
Number of subjects: 14
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-strength peroxide cleansing and gauze wraps
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-strength peroxide cleansing and Xeroform wraps
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline cleansing and gauze wraps
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline cleansing and Xeroform wraps
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial soap-and-water cleansing and gauze
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial soap-and-water cleansing and Xeroform gauze
Number of subjects: 92
Study 16272914 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable dressings with no pin cleansing
Number of subjects: 92
Study 12050912 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy (3 MU three times a week for 12 months)
Number of subjects: 122
Study 12050912 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 122
Study 11512193 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional oral hygiene and patient education in oral hygiene
Number of subjects: 83
Study 11512193 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 83
Study 7529523 — intervention group
Group type: EXPERIMENTAL
Intervention: BEP (bleomycin, etoposide, cisplatin)
Number of subjects: 54
Study 7529523 — intervention group
Group type: COMPARATOR
Intervention: EP (etoposide, cisplatin)
Number of subjects: 54
Study 1981905 — intervention group
Group type: EXPERIMENTAL
Intervention: Lozenge containing 11 mg (-)-menthol
Number of subjects: 62
Study 1981905 — intervention group
Group type: COMPARATOR
Intervention: Candy placebo lozenge
Number of subjects: 62
Study 318493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrallazine with cyclopenthiazide and oxprenolol
Number of subjects: 37
Study 318493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 318493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrallazine
Number of subjects: 37
Study 31496465 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-upper arm circumference (MUAC)
Number of subjects: 1023
Study 31496465 — intervention group
Group type: EXPERIMENTAL
Intervention: Height-for-age Z-score
Number of subjects: 1023
Study 31496465 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-for-age Z-score
Number of subjects: 1023
Study 31496465 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-for-height Z-score
Number of subjects: 1023
Study 30694800 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS-guided DES implantation
Number of subjects: 336
Study 30694800 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard DES implantation)
Number of subjects: 336
Study 27718079 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 2 (fixed SSDE, 15 mGy)
Number of subjects: 52
Study 27718079 — intervention group
Group type: COMPARATOR
Intervention: Protocol 1 (fixed CTDIvol, 15 mGy)
Number of subjects: 52
Study 24983847 — intervention group
Group type: EXPERIMENTAL
Intervention: 6RM bench press
Number of subjects: 30
Study 24983847 — intervention group
Group type: EXPERIMENTAL
Intervention: 6RM elastic band push-up
Number of subjects: 30
Study 24983847 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 23384256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion for 2 weeks followed by oral magnesium capsules for 4 weeks
Number of subjects: 80
Study 23384256 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 80
Study 21841065 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerosing treatment with polidocanol
Number of subjects: 29
Study 19214120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine 400 mg once daily
Number of subjects: 289
Study 19214120 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine twice daily
Number of subjects: 289
Study 15834456 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. pantoprazole
Number of subjects: 32
Study 15834456 — intervention group
Group type: COMPARATOR
Intervention: i.v. ranitidine
Number of subjects: 32
Study 12914883 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 665
Study 12914883 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 665
Study 12914883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 665
Study 10579480 — intervention group
Group type: EXPERIMENTAL
Intervention: R116301 (300 mg, oral administration)
Number of subjects: 0
Study 10579480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8776639 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ACT determination
Number of subjects: 100
Study 8776639 — intervention group
Group type: COMPARATOR
Intervention: Average of two ACT values
Number of subjects: 100
Study 1915428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicainoprol 400 mg
Number of subjects: 101
Study 1915428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicainoprol 600 mg
Number of subjects: 101
Study 1915428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicainoprol 200 mg
Number of subjects: 101
Study 1915428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 7146091 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0
Study 7146091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31409515 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose rosuvastatin (40 mg/day)
Number of subjects: 70
Study 31409515 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rosuvastatin (10 mg/day)
Number of subjects: 70
Study 31409515 — intervention group
Group type: COMPARATOR
Intervention: Control group (no statin treatment)
Number of subjects: 70
Study 31409515 — intervention group
Group type: COMPARATOR
Intervention: Control group (normocholesterolemic patients)
Number of subjects: 70
Study 30661935 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling stressing 2.5 cups per week CVs and 3.5 cups per week GLVs.
Number of subjects: 24
Study 30661935 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (n=12) receiving weekly 15- to 30-minute telephone dietary counseling focusing on general healthy eating for cancer survivors.
Number of subjects: 24
Study 28225185 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole nitrate-containing soap
Number of subjects: 75
Study 28225185 — intervention group
Group type: COMPARATOR
Intervention: Miconazole-free placebo soap
Number of subjects: 75
Study 25404659 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet behavioral intervention (IBI; n = 77)
Number of subjects: 154
Study 25404659 — intervention group
Group type: COMPARATOR
Intervention: Education-only Internet-delivered eating and activity control group (IDEA; n = 77)
Number of subjects: 154
Study 23359232 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically indicated preterm birth (PTB)
Number of subjects: 765
Study 23359232 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous preterm birth (SPTB)
Number of subjects: 765
Study 23359232 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically indicated PTB at < 30 weeks
Number of subjects: 765
Study 23359232 — intervention group
Group type: COMPARATOR
Intervention: Medically indicated PTB vs SPTB
Number of subjects: 765
Study 21546436 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 80 mg tid
Number of subjects: 259
Study 19049555 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-assisted clinical skills training (n = 66)
Number of subjects: 122
Study 19049555 — intervention group
Group type: COMPARATOR
Intervention: Postgraduates-assisted clinical skills training (n = 56)
Number of subjects: 122
Study 19049555 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment of competence
Number of subjects: 122
Study 16978286 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopy (Group A)
Number of subjects: 50
Study 16978286 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic varicocelectomy with isosulphan blue (Group B)
Number of subjects: 50
Study 16978286 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study 15554358 — intervention group
Group type: COMPARATOR
Intervention: Serine/Alanine (Ser/Ala) and Serine/Ser (Ser/Ser) genotypes in CFS patients
Number of subjects: 248
Study 15554358 — intervention group
Group type: COMPARATOR
Intervention: Serine allele positive patients
Number of subjects: 248
Study 11557911 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetylmorphine
Number of subjects: 8
Study 11557911 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoacetylmorphine
Number of subjects: 8
Study 11557911 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 8
Study 11557911 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetylmorphine and metabolites
Number of subjects: 8
Study 11557911 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-d3
Number of subjects: 8
Study 9226314 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily irradiation (2 Gy/day to 66-70 Gy) or twice daily irradiation (1.25 Gy B.I.D. to 70-75 Gy) +/− planned neck dissection (for ≥ N2A disease)
Number of subjects: 28
Study 7965282 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg
Number of subjects: 126
Study 7965282 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg
Number of subjects: 126
Study 7965282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 3658552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4), 6 mg elemental Mg/kg body weight, over 1 h
Number of subjects: 39
Study 3658552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4)
Number of subjects: 39
Study 3658552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39